Biontech stock.

RATIOS/PROFITABILITY. EPS (TTM) 39.99. P/E (TTM) 2.26. Fwd P/E (NTM) -37.86. EBITDA (TTM) -188.805M. ROE (TTM) 0.56%. Revenue (TTM) 2.935B. Gross Margin (TTM) 79.38%. Net Margin (TTM) 4.14%.Find out all the key statistics for BioNTech SE (BNTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta (5Y ...BioNTech SE: Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, Stock BioNTech SE | Nasdaq: BNTX | NasdaqBioNTech hit its lowest point in the month on Feb. 24 at $138.57. The stock has a 52-week low of $90.29 and a 52-week high of $464. Over the past 12 months, the stock is up more than 43%.Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis.

It’s no secret that investors want to achieve stock market success when they start trading shares — but doing so largely comes down to figuring out the best stocks to invest in and...Answering this question will take us one step closer to our new normal. We know that the vaccines now available across the world will protect their recipients from getting sick wit...

BNTX Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View BioNTech SE Sponsored ADR BNTX stock quote prices, financial information, real-time forecasts, and company news from CNN. While BioNTech’s has no need to beg investors for more capital, the company will still have to navigate expectations of shareholders who bought it as a Covid stock. Shares in BioNTech have ...

Get Biontech SE (BNTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsModerna and BioNTech are no longer minting money from Covid vaccines. But both have strong drug pipelines and plenty of cash.Aug 18, 2023 · Moderna and BioNTech are no longer minting money from Covid vaccines. But both have strong drug pipelines and plenty of cash. What's Going With BioNTech Stock On Monday? Monday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the ...

Swat car

Mar 20, 2024 ... BioNTech said that writedowns of inventory from its partner Pfizer (PFE) lowered revenue by 291.3 million euros ($315.9 million) in the quarter.

BioNTech and Pfizer's COVID-19 vaccine, COMIRNATY, generated $36.8 billion in sales in 2021, making it the highest-selling pharmaceutical product in a single year. BioNTech's stock has faced ...BioNTech hit its lowest point in the month on Feb. 24 at $138.57. The stock has a 52-week low of $90.29 and a 52-week high of $464. Over the past 12 months, the stock is up more than 43%.BioNTech's Performance Conundrum. PFE stock Vs. BNTX stock YTD performance (as of 8 Sep 21). Despite the shared success in Comirnaty, only one of them, BioNTech, is the clear winner so far. Its ...Why BioNTech Stock Was Sinking Today. Why Shares of BioNTech Rose Friday. 2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years. Why Shares of BioNTech Slumped Monday.BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5 ...BioNTech to pay an upfront consideration of approximately £362 million in cash and BioNTech shares, to acquire 100% of remaining InstaDeep shares following BioNTech’s Series B investment in 2022That's why it's important to consider a stock like BioNTech (BNTX 1.59%). Sure, the stock has climbed 962% since the beginning of last year. But a lot has happened since. The company's future ...

See BioNTech SE (BNTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Moderna is not alone. In September of 2019, Bill Gates initially invested $55 million on a pre-IPO equity investment into BioNtech. Gates’s investment in BioNtech may probably higher. Today, Gates’ investment is now worth over $550 million dollars, based on the company’s market cap at the time of writing.Biontech Se Biontech Se Adr is listed on the London Stock Exchange trading with ticker code 0A3M.L. It has a market capitalisation of $21.91b, with approximately 240.99m shares in issue. Over the ...Jul 8, 2021 · BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by about 2% over the last week (five trading days) and also remains down by about ... BioNTech shares have soared 171.6% year to date through Friday and Pfizer's stock has lost 7.1%, while the S&P 500 SPX, -0.14% has gained 8.6%. Advertisement Read NextAug 20, 2020 ... NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today shared additional Phase 1 safety and ...BioNTech SE (BNTX) is a publicly traded biotechnology business based in the US. It opened the day at $92.56 after a previous close of $91.67. During the day the price has varied from a low of $92.4132 to a high of $93.48. The latest price was $92.72 (25 minute delay). BioNTech is listed on the NASDAQ and employs 6,133 staff.

View the latest BioNTech SE ADR (BNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

View the latest BioNTech SE ADR (BNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.MAINZ, Germany, and ROCKVILLE, Maryland, USA, June 29, 2023 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”) today announced that the first patient with non-small cell lung cancer (NSCLC) has been treated in a pivotal Phase 3 trial evaluating the companies’ next-generation anti-CTLA-4 …Momentum, however, is rated "D+" with BioNTech's stock showing a decline over the past year, down by 12.85%, significantly underperforming the S&P 500 which has grown by 20.26%.A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.May 6, 2024 ... Fiscal discipline is important going forward, notes Hartaj Singh on Moderna (MRNA). He discusses biotech stocks Moderna and Gilead Sciences ...BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by about 2% over the last week (five trading days) and also remains down by about ...Pfizer Inc’s (NYSE:PFE) German partner, BioNTech SE (NASDAQ:BNTX), reported fourth-quarter 2023 EPS of fiscal year Q4 GAAP EPS of €1.90 versus €9.26, a year ago, equivalent to $2.04 missing ...Contact. For any further questions, you can reach us daily from 12:00 to 16:00 CET under +49 6131 9084-1291. Alternatively, you can also send us an email: [email protected]. Go to contact form. Join us on our mission to improve global health by developing the next generation of immunotherapies and vaccines. BioNTech is growing - and this creates ...

Fabindia shop online

Last Earnings Release. Mar. 20, 2024. Next Ex-Dividend Date. N/A. Last Ex-Dividend Date. Jun. 02, 2022. In depth view into BNTX (BioNTech) stock including the latest price, news, dividend history, earnings information and financials.

In my view, it isn't too late to buy BioNTech stock whatsoever, and here's why. Right now, it has 2.3 billion euros in cash, and only 286 million euros in debt. And its trailing 12-month operating ...Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.5, a high estimate of $171.00, and a low estimate of $99.00. This current average has decreased by ...Mar 20, 2024 ... Shares of Pfizer rose a fraction to 27.70. BioNTech Stock Faces Continues Declines. Despite launching new booster shots to target more updated ...BioNTech stock lifted a fraction Monday after Covid vaccine sales dropped again in the first quarter, amid wide losses. Investor's Business Daily • 7 days ago BNTX6 days ago · Stock analysis for BioNTech SE (BNTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. BioNTech's stock has underperformed the broader market as it is off 27% in the last year compared to the SP500 being up 32%. StockCharts.com. Per Fintel, BioNTech's short interest makes up 3.38% ...BioNTech announced on June 2, 2023 the start of its new share buyback program announced in March 2023. The Company intends to repurchase own shares in an amount of up to $0.5 billion until November 2, 2023. Announcement pursuant to Art 5 (1)a) EU Regulation 596_2014 and Art 2 (1) EU Delegated Regulation 2016_1052_Share …BioNTech SE analysts consensus, targets, ratings and recommendations | Nasdaq: BNTX | Nasdaq BioNTech. BioNTech SE ( / biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek [2] short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Apr 26, 2024 · BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh Mar. 20, 2024 at 7:30 a.m. ET by Tomi Kilgore Biontech 4Q Rev EUR1.48B Buy Moderna and BioNTech Stock. Both Pharmas Have Strong Drug Pipelines and Plenty of Cash. By Andrew Bary. Aug 18, 2023, 5:02 pm EDT. Share. Resize. Reprints.

SPX. +0.48%. Shares of BioNTech SE sank toward a more than two-year low Wednesday, after the Germany-based biotechnology company reported fourth-quarter results that fell sharply below ...BioNTech's stock has underperformed the broader market as it is off 27% in the last year compared to the SP500 being up 32%. StockCharts.com Per Fintel, BioNTech's short interest makes up 3.38% of ...BNTX Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View BioNTech SE Sponsored ADR BNTX stock quote prices, financial information, real-time forecasts, and company news from CNN.Instagram:https://instagram. talking top Cash Amount. Record Date. Pay Date. Jun 2, 2022. $2.111. Jun 3, 2022. Jun 17, 2022. * Dividend amounts are adjusted for stock splits when applicable. Get the latest dividend data for BioNTech SE (BNTX), including dividend history, yield, key dates, growth and other metrics. fccu org That's why it's important to consider a stock like BioNTech (BNTX 1.59%). Sure, the stock has climbed 962% since the beginning of last year. But a lot has happened since. The company's future ...BioNTech announced on June 2, 2023 the start of its new share buyback program announced in March 2023. The Company intends to repurchase own shares in an amount of up to $0.5 billion until November 2, 2023. Announcement pursuant to Art 5 (1)a) EU Regulation 596_2014 and Art 2 (1) EU Delegated Regulation 2016_1052_Share … web to pdf SPX. +0.48%. Shares of BioNTech SE sank toward a more than two-year low Wednesday, after the Germany-based biotechnology company reported fourth-quarter results that fell sharply below ... how do you block your number when calling BioNTech SE. An der Goldgrube 12. 55131 Mainz, Germany. T: +49 6131 9084-0 F: +49 6131 9084-2121 [email protected]. CompanyNov 6, 2023 ... Secretive German billionaire twins cut Covid vaccine bet after banking 550% gain ... The shares of vaccine maker BioNTech have lost some value. pluto tv review Open 90.72. Day High 90.99. Day Low 89.38. Prev Close 90.88. 52 Week High 125.83. 52 Week High Date 08/31/23. 52 Week Low 85.21. 52 Week Low Date 03/20/24. Market Cap 21.481B. Shares Out 237.73M.... personal services 5:53 AM. BioNTech (Filer) Form 6-K. Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. (Data available from 1/1/2016 forward) This page (NASDAQ:BNTX) was last updated on 5/8/2024 by MarketBeat.com Staff. blade runner 2049 full movie 4 days ago · A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Nov 6, 2023 · (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to the prior year, as the commercial revenues were down sharply. The company revised down its COVID ... Pfizer (PFE 1.19%) stock was down 3.5%. Shares of BioNTech (BNTX 2.14%) and Moderna (MRNA 0.66%) were sinking 7.6% and 8.2%, respectively. However, Pfizer and BioNTech actually had good news. The ... coordinate finder Jan 11, 2021 ... More data is needed to see if new coronavirus variant will bring additional risks to the efficacy of its vaccines, but BioNTech stocks ... walmart's online shopping A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. airindia in BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for … pdf finder At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. BioNTech SE (BNTX) is a publicly traded biotechnology business based in the US. It opened the day at $92.56 after a previous close of $91.67. During the day the price has varied from a low of $92.4132 to a high of $93.48. The latest price was $92.72 (25 minute delay). BioNTech is listed on the NASDAQ and employs 6,133 staff.